Circulation Research, Vol 56, 651-665, Copyright © 1985 by American Heart Association

ARTICLES

Animal models for protecting ischemic myocardium: results of the NHLBI Cooperative Study. Comparison of unconscious and conscious dog models

KA Reimer, RB Jennings, FR Cobb, RH Murdock, JC Greenfield Jr, LC Becker, BH Bulkley, GM Hutchins, RP Schwartz Jr and KR Bailey

The Animal Models for Protecting Ischemic Myocardium Study was undertaken for the purpose of developing reproducible animal models that could be used to assess interventions designed to limit infarct size. This paper describes the results obtained in an unconscious dog model and in a conscious dog model, developed in three participating laboratories. The unconscious dog model, involving reperfusion after 3 hours of ischemia in open-chest dogs, was intended to determine whether therapy followed by early reperfusion would limit infarct size more than reperfusion alone. The conscious dog model used chronically instrumented dogs and permanent coronary occlusion to better mimic myocardial infarction in man. In both models, the proximal circumflex artery was occluded, and the primary experimental endpoint was infarct size, as measured by histological techniques 3 days after the initial occlusion. Infarct size was analyzed in relation to baseline variables including the anatomic area at risk, collateral blood flow to the subepicardial zone of ischemia and hemodynamic determinants of myocardial metabolic demand. Most of the variation in infarct size in control dogs could be related to variation in the area at risk, collateral blood flow, and rate pressure product. Using multivariate analysis and groups of 15 dogs, an intervention that limited infarct size by 10-13% of the area at risk would have been detected 50% of the time. Larger treatment effects would be detected more readily, and smaller effects often would be missed, unless group sizes were larger. Two drugs, verapamil and ibuprofen, were evaluated in both models, with experimental group sizes averaging 13 and 20 dogs, in the unconscious and conscious models, respectively. Three of 15 verapamil-treated dogs in the unconscious model study had much smaller infarcts than expected from baseline parameters. With these exceptions, neither drug limited infarct size in either model.

This article has been cited by other articles:

				M. Abdellaoui, G. Rioufol, and G. Finet Letter by Abdellaoui et al Regarding Article, "Intracoronary Compared With Intravenous Bolus Abciximab Application in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention" Circulation, January 27, 2009; 119(3): e19 - e19. [Full Text] [PDF]

				P. Ferdinandy, R. Schulz, and G. F. Baxter Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning Pharmacol. Rev., December 1, 2007; 59(4): 418 - 458. [Abstract] [Full Text] [PDF]

				M. T. Dirksen, G. J. Laarman, M. L. Simoons, and D. J.G.M. Duncker Reperfusion injury in humans: A review of clinical trials on reperfusion injury inhibitory strategies Cardiovasc Res, June 1, 2007; 74(3): 343 - 355. [Abstract] [Full Text] [PDF]

				W. Wijns and G. R. Heyndrickx Cold Cardioplegia for Acute Infarction: A Viable Adjunct to Reperfusion Therapy? J. Am. Coll. Cardiol., January 16, 2007; 49(2): 261 - 262. [Full Text] [PDF]

				A. Skyschally, P. Gres, S. Hoffmann, M. Haude, R. Erbel, R. Schulz, and G. Heusch Bidirectional Role of Tumor Necrosis Factor-{alpha} in Coronary Microembolization: Progressive Contractile Dysfunction Versus Delayed Protection Against Infarction Circ. Res., January 5, 2007; 100(1): 140 - 146. [Abstract] [Full Text] [PDF]

				H. L. Collins and S. E. DiCarlo Acute exercise increases the ventricular arrhythmia threshold via the intrinsic adenosine receptor system in conscious hypertensive rats Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1020 - H1026. [Abstract] [Full Text] [PDF]

				R. J. Gibbons and C. L. Grines Acute PCI for ST-Segment Elevation Myocardial Infarction: Is Later Better Than Never? JAMA, June 15, 2005; 293(23): 2930 - 2932. [Full Text] [PDF]

				H. L. Collins, A. M. Loka, and S. E. DiCarlo Daily exercise-induced cardioprotection is associated with changes in calcium regulatory proteins in hypertensive rats Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H532 - H540. [Abstract] [Full Text] [PDF]

				L. Argaud, G. Rioufol, M. Lievre, L. Bontemps, P. Legalery, M. Stumpf, G. Finet, R. Itti, X. Andre-Fouet, and M. Ovize Preconditioning during coronary angioplasty: no influence of collateral perfusion or the size of the area at risk Eur. Heart J., November 2, 2004; 25(22): 2019 - 2025. [Abstract] [Full Text] [PDF]

				P. Zong, S. Setty, W. Sun, R. Martinez, J. D. Tune, I. V. Ehrenburg, E. N. Tkatchouk, R. T. Mallet, and H. F. Downey Intermittent Hypoxic Training Protects Canine Myocardium from Infarction Experimental Biology and Medicine, September 1, 2004; 229(8): 806 - 812. [Abstract] [Full Text] [PDF]

				G. Ndrepepa, J. Mehilli, M. Schwaiger, H. Schuhlen, S. Nekolla, S. Martinoff, C. Schmitt, J. Dirschinger, A. Schomig, and A. Kastrati Prognostic Value of Myocardial Salvage Achieved by Reperfusion Therapy in Patients with Acute Myocardial Infarction J. Nucl. Med., May 1, 2004; 45(5): 725 - 729. [Abstract] [Full Text] [PDF]

				M. T Dirksen, G. Laarman, A. W.J van 't Hof, G. Guagliumi, W. A.L Tonino, L. Tavazzi, D. J.G.M Duncker, M. L Simoons, and on behalf of the PARI-MI Investigators The effect of ITF-1697 on reperfusion in patients undergoing primary angioplasty: Safety and efficacy of a novel tetrapeptide, ITF-1697 Eur. Heart J., March 1, 2004; 25(5): 392 - 400. [Abstract] [Full Text] [PDF]

				J. Vinten-Johansen Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury Cardiovasc Res, February 15, 2004; 61(3): 481 - 497. [Abstract] [Full Text] [PDF]

				S. L Hale, M. W Dae, and R. A Kloner Hypothermia during reperfusion limits 'no-reflow' injury in a rabbit model of acute myocardial infarction Cardiovasc Res, September 1, 2003; 59(3): 715 - 722. [Abstract] [Full Text] [PDF]

				C.-K. Wong, J.K. French, M.W. Krucoff, W. Gao, P.E. Aylward, and H.D. White Slowed ST segment recovery despite early infarct artery patency in patients with Q waves at presentation with a first acute myocardial infarction. Implications of initial Q waves on myocyte reperfusion Eur. Heart J., September 2, 2002; 23(18): 1449 - 1455. [Abstract] [Full Text] [PDF]

				C.-K. Wong, J.K. French, J. Andrews, M.J. Frey, A.A.J. Adgey, P.E. Aylward, and H.D. White Usefulness of the presenting electrocardiogram in predicting myocardial salvage with thrombolytic therapy in patients with a first acute myocardial infarction Eur. Heart J., March 1, 2002; 23(5): 399 - 404. [Abstract] [Full Text] [PDF]

				D.J. Hearse Ischaemia, reperfusion and cardioprotection: successes and failures in the journey from molecule to man Eur. Heart J. Suppl., June 1, 2001; 3(suppl_C): C11 - C21. [Abstract] [PDF]

				E. F Unger Experimental evaluation of coronary collateral development Cardiovasc Res, February 16, 2001; 49(3): 497 - 506. [Abstract] [Full Text] [PDF]

				F. H. H. Leenen and B. Yuan Mortality After Coronary Artery Occlusion in Different Models of Cardiac Hypertrophy in Rats Hypertension, February 1, 2001; 37(2): 209 - 215. [Abstract] [Full Text] [PDF]

				J. G. Kingma Jr., S. Plante, and P. Bogaty Platelet GPIIb/IIIa receptor blockade reduces infarct size in a canine model of ischemia-reperfusion J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2317 - 2324. [Abstract] [Full Text] [PDF]

				P. Golino, M. Ragni, P. Cirillo, A. Scognamiglio, A. Ravera, C. Buono, A. Guarino, O. Piro, C. Lambiase, F. Botticella, et al. Recombinant human, active site-blocked factor VIIa reduces infarct size and no-reflow phenomenon in rabbits Am J Physiol Heart Circ Physiol, May 1, 2000; 278(5): H1507 - H1516. [Abstract] [Full Text] [PDF]

				C. Whan Lee, S.-W. Park, G.-Y. Cho, M.-K. Hong, J.-J. Kim, D.-H. Kang, J.-K. Song, H.-J. Lee, and S.-J. Park Pressure-derived fractional collateral blood flow: a primary determinant of left ventricular recovery after reperfused acute myocardial infarction J. Am. Coll. Cardiol., March 15, 2000; 35(4): 949 - 955. [Abstract] [Full Text] [PDF]

				M. B. Forman, J. V. Vitola, C. E. Velasco, J. J. Murray, R. K. Dubey, and E. K. Jackson Sustained Reduction in Myocardial Reperfusion Injury with an Adenosine Receptor Antagonist: Possible Role of the Neutrophil Chemoattractant Response J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 929 - 938. [Abstract] [Full Text]

				L. M Goncalves Angiogenic growth factors: potential new treatment for acute myocardial infarction? Cardiovasc Res, January 14, 2000; 45(2): 294 - 302. [Abstract] [Full Text] [PDF]

				D. J Hearse The elusive coypu: the importance of collateral flow and the search for an alternative to the dog Cardiovasc Res, January 1, 2000; 45(1): 215 - 219. [Full Text] [PDF]

				T. F. Christian, P. B. Berger, M. K. O’Connor, D. O. Hodge, and R. J. Gibbons Threshold Values for Preserved Viability With a Noninvasive Measurement of Collateral Blood Flow During Acute Myocardial Infarction Treated by Direct Coronary Angioplasty Circulation, December 14, 1999; 100(24): 2392 - 2395. [Abstract] [Full Text] [PDF]

				F. Grund, H. T. Sommerschild, T. Lyberg, K. A. Kirkeboen, and A. Ilebekk Microembolization in pigs: effects on coronary blood flow and myocardial ischemic tolerance Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H533 - H542. [Abstract] [Full Text] [PDF]

				R. Schulz, H. Post, A. Jalowy, U. Backenkohler, H. Dorge, C. Vahlhaus, and G. Heusch Unique Cardioprotective Action of the New Calcium Antagonist Mibefradil Circulation, January 19, 1999; 99(2): 305 - 311. [Abstract] [Full Text] [PDF]

				L. Galiuto, A. N. DeMaria, K. May-Newman, U. del Balzo, K. Ohmori, V. Bhargava, S. F. Flaim, and S. Iliceto Evaluation of dynamic changes in microvascular flow during ischemia-reperfusion by myocardial contrast echocardiography J. Am. Coll. Cardiol., October 1, 1998; 32(4): 1096 - 1101. [Abstract] [Full Text] [PDF]

				S. V. Pislaru, L. Barrios, T. Stassen, L. Jun, C. Pislaru, and F. Van de Werf Infarct Size, Myocardial Hemorrhage, and Recovery of Function After Mechanical Versus Pharmacological Reperfusion : Effects of Lytic State and Occlusion Time Circulation, July 15, 1997; 96(2): 659 - 666. [Abstract] [Full Text]

				B. I. Jugdutt, M. J. Joljart, and M. I. Khan Rate of Collagen Deposition During Healing and Ventricular Remodeling After Myocardial Infarction in Rat and Dog Models Circulation, July 1, 1996; 94(1): 94 - 101. [Abstract] [Full Text]

				V. Richard, C. E. Murry, and K. A. Reimer Healing of Myocardial Infarcts in Dogs : Effects of Late Reperfusion Circulation, October 1, 1995; 92(7): 1891 - 1901. [Abstract] [Full Text]

				E. T. Hasche, C. Fernandes, S. B. Freedman, and R. W. Jeremy Relation Between Ischemia Time, Infarct Size, and Left Ventricular Function in Humans Circulation, August 15, 1995; 92(4): 710 - 719. [Abstract] [Full Text]

				R. W. Smalling, S. Feld, N. Ramanna, J. Amirian, P. Felli, W. K. Vaughn, C. Swenson, and A. Janoff Infarct Salvage With Liposomal Prostaglandin E1 Administered by Intravenous Bolus Immediately Before Reperfusion in a Canine Infarction-Reperfusion Model Circulation, August 15, 1995; 92(4): 935 - 943. [Abstract] [Full Text]

				B. R. Ito Gradual Onset of Myocardial Ischemia Results in Reduced Myocardial Infarction : Association With Reduced Contractile Function and Metabolic Downregulation Circulation, April 1, 1995; 91(7): 2058 - 2070. [Abstract] [Full Text]

				F. Ottani, M. Galvani, D. Ferrini, F. Sorbello, P. Limonetti, D. Pantoli, and F. Rusticali Prodromal Angina Limits Infarct Size : A Role for Ischemic Preconditioning Circulation, January 15, 1995; 91(2): 291 - 297. [Abstract] [Full Text]

				R. J. Gibbons, D. R. Holmes, G. S. Reeder, K. R. Bailey, M. R. Hopfenspirger, B. J. Gersh, and The Mayo Coronary Care Unit and Catheterization La Immediate Angioplasty Compared with the Administration of a Thrombolytic Agent Followed by Conservative Treatment for Myocardial Infarction N. Engl. J. Med., March 11, 1993; 328(10): 685 - 691. [Abstract] [Full Text]

				A. E. Skolnick and W. H. Frishman Calcium Channel Blockers in Myocardial Infarction Arch Intern Med, July 1, 1989; 149(7): 1669 - 1677. [Abstract] [PDF]